A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Unless otherwise indicated in this report "DaVita", "the Company" "we", "us", "our" and other similar terms refer to DaVita Inc. and its consolidated subsidiaries. Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are made available free of charge through our website, located at http://www.davita.com, as soon as reasonably practicable after the reports are filed with or furnished to the Securities and Exchange Commission (SEC). The SEC also maintains a website at http://www.sec.gov where these reports and other information about us can be obtained. The contents of our website are not incorporated by reference into this report. Overview of DaVita Inc. DaVita is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | % of Total |
|---|---|---|---|---|---|---|
Operating Segments | $10.64B | $10.58B | $10.91B | $11.37B | $11.77B | 49% |
Medicare and Medicare Advantage | $6.13B | $6.04B | $6.10B | $6.37B | $6.74B | 28% |
Commercial Payors | $3.40B | $3.44B | $3.62B | $3.78B | $3.81B | 16% |
Other Government Payors | $463M | $465M | $500M | $718M | $914M | 4% |
Medicaid and Managed Medicaid | $782M | $760M | $834M | $864M | $872M | 4% |
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 13.6B | 13.6B | 12.8B | 12.1B | 11.6B | 11.6B |
| Net Income | 747M | 747M | 936M | 692M | 560M | 978M |
| EPS | $9.84 | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Free Cash Flow | 1.3B | 1.3B | 1.5B | 1.5B | 961M | 1.3B |
| ROIC | 12.6% | 15.5% | 14.7% | 10.9% | 8.6% | 11.5% |
| Gross Margin | 36.7% | 36.7% | 37.6% | 34.8% | 32.6% | 34.1% |
| Debt/Equity | 0.00 | -19.94 | 101.86 | 10.64 | 16.92 | 16.09 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | 2.0B | 2.0B | 2.1B | 1.6B | 1.3B | 1.8B |
| Operating Margin | 15.0% | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| ROE | 0.0% | -281.8% | 773.1% | 65.5% | 78.7% | 129.5% |
| Shares Outstanding | 76M | 76M | 87M | 93M | 96M | 110M |
DAVITA INC. passes 4 of 9 quality checks, suggesting mixed fundamentals.
DAVITA INC. trades at 15.4x trailing earnings, compared to its 15-year median P/E of 14.3x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 7.7x vs a median of 9.4x. The company's 5-year average ROIC is 12.3% with a gross margin of 35.2%. Total shareholder yield (buybacks) is 11.4%. At current prices, the estimated annualized return to fair value is +18.1%.
DAVITA INC. (DVA) has a current P/E ratio of 15.4, compared to its historical median P/E of 14.3. The stock is currently considered Fair based on its historical valuation range.
DAVITA INC. (DVA) has a 5-year average return on invested capital (ROIC) of 12.3%. This indicates solid capital allocation.
DAVITA INC. (DVA) has a market capitalization of $11.5B. It is classified as a large-cap stock.
DAVITA INC. (DVA) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 11.37%.
Based on historical P/E analysis, DAVITA INC. (DVA) appears fair. The current P/E of 15.4 is 8% above its historical median of 14.3. The estimated fair value CAGR (P/E method) is 19.6%.
DAVITA INC. (DVA) operates in the Services-Misc Health & Allied Services, Nec industry, within the Healthcare sector.
DAVITA INC. (DVA) reported annual revenue of $13.6 billion in its most recent fiscal year, based on SEC EDGAR filings.
DAVITA INC. (DVA) has a net profit margin of 5.5%. This is a modest margin.
DAVITA INC. (DVA) generated $1.3 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DAVITA INC. (DVA) reported earnings per share (EPS) of $9.84 in its most recent fiscal year.
DAVITA INC. (DVA) has a return on equity (ROE) of -281.8%. A negative ROE may indicate losses or negative equity.
DAVITA INC. (DVA) has a 5-year average gross margin of 35.2%. This indicates decent pricing power.
The Ledger Terminal provides 19 years of financial data for DAVITA INC. (DVA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DAVITA INC. (DVA) has a book value per share of $-8.58, based on its most recent annual SEC filing.